Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer
Our study indicated the potential significance of anti-COPT1-IgG and anti-COPT1-IgM autoantibodies as novel biomarkers for the detection of NSCLC. Furthermore, the combination of anti-COPT1-IgG and anti-COPT1-IgM improved the diagnostic value.
Authors
- Liping Dai
- Siyu Liu (ORCID: https://orcid.org/0000-0002-7611-8844)
- Jing Li (ORCID: https://orcid.org/0000-0002-3977-1641)
- Xiaobin Cao (ORCID: https://orcid.org/0009-0000-7276-8463)
- Songyun Ouyang (ORCID: https://orcid.org/0000-0003-1707-1537)
- Lulu Zhang
- Yutong Li (ORCID: https://orcid.org/0009-0008-6496-8850)
- A. Liu
- Jingjing Liu (ORCID: https://orcid.org/0000-0002-7471-9435)
- Wenke Sun
- Hanke Ma
- Fengqi Chen
Institutions
- Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-11
- DOI
- https://doi.org/10.3389/fimmu.2025.1455095
- Citations
- 3
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 4.08